- JP-listed companies
- TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
- Income statement
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.【JP:E25678】Income statement
Market cap
P/E ratio
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | |
| Revenue | 271,230 | 285,168 | 295,957 | 290,498 | 290,135 | 279,773 | 280,092 | 261,551 | 288,527 | 281,980 | 268,203 | 301,381 |
| Cost of revenue | - | 108,904 | 111,275 | 112,240 | 113,143 | 101,525 | 97,154 | 91,206 | 108,337 | 106,050 | 104,371 | 123,531 |
| Gross profit | - | 176,264 | 184,682 | 178,258 | 176,991 | 178,248 | 182,938 | 170,345 | 180,190 | 175,929 | 163,831 | 177,850 |
| Gross margin (%) | - | |||||||||||
| Operating expenses | - | 140,873 | 143,009 | 146,273 | 147,935 | 146,260 | 146,007 | 138,951 | 158,923 | 156,021 | 153,088 | 154,831 |
| Operating income | - | 35,337 | 41,683 | 31,974 | 28,878 | 31,966 | 36,977 | 31,211 | 21,460 | 19,965 | 10,743 | 23,018 |
| Income before tax | 46,201 | 44,173 | 51,244 | 39,576 | 36,775 | 38,036 | 42,140 | 40,851 | 25,010 | 25,946 | 18,412 | 30,444 |
| Provision for income taxes | - | 15,630 | 17,305 | 14,102 | 11,927 | 11,750 | 14,701 | 14,658 | 8,423 | 7,782 | 6,448 | 8,196 |
| Net income | 24,357 | 26,320 | 32,692 | 24,528 | 23,882 | 30,205 | 33,368 | 49,825 | 21,887 | 15,194 | 14,950 | 21,302 |
| Earnings per share | 296.2 | 325.26 | 403.18 | 302.57 | 277.75 | 360.18 | 396.54 | 608.8 | 257.23 | 166.84 | 161.12 | 231.73 |
| Diluted EPS | - | 325.22 | 403.07 | 302.42 | 277.59 | 359.92 | 396.2 | 608.22 | 256.93 | 166.63 | 160.93 | 231.43 |